The positive role of traditional Chinese medicine as an adjunctive therapy for cancer
X Zhang, H Qiu, C Li, P Cai, F Qi - Bioscience trends, 2021 - jstage.jst.go.jp
Traditional Chinese medicine (TCM), especially Chinese herbal medicines and
acupuncture, has been traditionally used to treat patients with cancers in China and other …
acupuncture, has been traditionally used to treat patients with cancers in China and other …
[HTML][HTML] Overview and countermeasures of cancer burden in China
Cancer is one of the leading causes of human death worldwide. Treatment of cancer
exhausts significant medical resources, and the morbidity and mortality caused by cancer is …
exhausts significant medical resources, and the morbidity and mortality caused by cancer is …
Cancer incidence, mortality, and burden in China: a time‐trend analysis and comparison with the United States and United Kingdom based on the global …
H Qiu, S Cao, R Xu - Cancer communications, 2021 - Wiley Online Library
Background Cancer is one of the leading causes of death and a main economic burden in
China. Investigating the differences in cancer patterns and control strategies between China …
China. Investigating the differences in cancer patterns and control strategies between China …
[HTML][HTML] m6A-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD
F Xu, X Huang, Y Li, Y Chen, L Lin - Molecular Therapy-Nucleic Acids, 2021 - cell.com
Lung adenocarcinoma (LUAD) is the most frequent subtype of lung cancer worldwide.
However, the survival rate of LUAD patients remains low. N6-methyladenosine (m 6 A) and …
However, the survival rate of LUAD patients remains low. N6-methyladenosine (m 6 A) and …
[HTML][HTML] Updated epidemiology of gastric cancer in Asia: Decreased incidence but still a big challenge
Simple Summary Gastric cancer (GC) is regarded as one of the most perilous malignancies
globally, with over one billion new cases and seven hundred and eighty-three thousand …
globally, with over one billion new cases and seven hundred and eighty-three thousand …
[HTML][HTML] Recent advances in chitosan and its derivatives in cancer treatment
J Ding, Y Guo - Frontiers in Pharmacology, 2022 - frontiersin.org
Cancer has become a main public health issue globally. The conventional treatment
measures for cancer include surgery, radiotherapy and chemotherapy. Among the various …
measures for cancer include surgery, radiotherapy and chemotherapy. Among the various …
Trends in cancer mortality in China from 2004 to 2018: A nationwide longitudinal study
D Jiang, L Zhang, W Liu, Y Ding, J Yin… - Cancer …, 2021 - Wiley Online Library
Background The long‐term trend in cancer death in a rapidly developing country provides
information for cancer prophylaxis. Here, we aimed to identify the trends in cancer mortality …
information for cancer prophylaxis. Here, we aimed to identify the trends in cancer mortality …
Design and engineering of hypoxia and acidic pH dual‐stimuli‐responsive intelligent fluorescent nanoprobe for precise tumor imaging
S Chen, M Chen, J Yang, X Zeng, Y Zhou, S Yang… - Small, 2021 - Wiley Online Library
Stimulus‐responsive fluorescence imaging modality shows great promise for detection of
tumor due to the advantages of high sensitivity, simplicity and noninvasiveness. However …
tumor due to the advantages of high sensitivity, simplicity and noninvasiveness. However …
Sintilimab versus docetaxel as second‐line treatment in advanced or metastatic squamous non‐small‐cell lung cancer: an open‐label, randomized controlled phase 3 …
Y Shi, L Wu, X Yu, P Xing, Y Wang… - Cancer …, 2022 - Wiley Online Library
Abstract Background Treatment options for Chinese patients with locally advanced or
metastatic squamous‐cell non‐small‐cell lung cancer (sqNSCLC) after failure of first‐line …
metastatic squamous‐cell non‐small‐cell lung cancer (sqNSCLC) after failure of first‐line …
[HTML][HTML] Research progress in inducing immunogenic cell death of tumor cells
D Xie, Q Wang, G Wu - Frontiers in immunology, 2022 - frontiersin.org
Immunogenic cell death (ICD) is a regulated cell death (RCD) pathway. In response to
physical and chemical signals, tumor cells activate specific signaling pathways that stimulate …
physical and chemical signals, tumor cells activate specific signaling pathways that stimulate …